12:00 AM
 | 
Jun 15, 2009
 |  BC Week In Review  |  Company News  |  Deals

biOasis, University of British Columbia deal

biOasis and the university will conduct research on the use of melanotransferrin ( p97) to deliver therapeutics across the blood-brain barrier. biOasis...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >